Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - MEDIS TECHNOLOGIES LTD | ex99-1_16638.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): November 4, 2009
Medis
Technologies Ltd.
(Exact
name of Registrant as specified in its charter)
|
Delaware
(State
of incorporation)
|
0-30391
(Commission
File No.)
|
13-3669062
(IRS
Employer Identification No.)
|
805
Third Avenue
New
York, New York 10022
(Address
of principal executive offices)
Registrant’s
telephone number: (212) 935-8484
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the Registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01. Other
Events.
On
November 4, 2009, current and former employees of Medis El Ltd. (“Medis El”) and
More Energy Ltd. (“More”), each a wholly owned subsidiary of Medis Technologies
Ltd. (“Medis”), commenced liquidation actions with respect to each of Medis El
and More in court in Israel. Medis intends to cooperate in these
proceedings to facilitate an orderly liquidation of each of Medis El and
More. Medis expects a liquidator for Medis El and More to be
appointed by the Israeli courts.
Item
9.01. Financial
Statements and Exhibits.
|
(a)
|
Financial
Statements of Businesses Acquired -
None
|
|
(b)
|
Pro
Forma Financial Information - None
|
|
(c)
|
Shell
Company Transactions - None
|
|
(d)
|
Exhibits:
|
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press
Release dated November 4, 2009
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
November 4, 2009
|
MEDIS
TECHNOLOGIES LTD.
|
|||
|
|
By:
|
/s/ Jose Mejia | |
| Name: Jose Mejia | |||
| Title: Chief Executive Officer | |||